(5) Changes in the scope of consolidation
Accounting and measurement policies
Scope of consolidation
Immaterial subsidiaries are not included in consolidation but are instead reported in non-current financial assets (see Note (36) “Other financial assets”).
The scope of consolidation changed as follows in the reporting period:
Fully consolidated companies as of Dec. 31, 2020 |
|
|
|
326 |
|---|---|---|---|---|
Additions |
|
Companies established |
|
1 |
|
Acquisitions |
|
– |
|
|
Materiality |
|
4 |
|
Retirements |
|
Liquidations/mergers |
|
-5 |
|
Divestments |
|
– |
|
|
Immateriality |
|
-1 |
|
|
Loss of control |
|
– |
|
Fully consolidated companies as of Dec. 31, 2021 |
|
|
|
325 |
Subsidiaries rated at-equity as of Dec. 31, 2020 |
|
|
|
1 |
Subsidiaries rated at-equity as of Dec. 31, 2021 |
|
|
|
2 |
Non-consolidated subsidiaries as of Dec. 31, 2020 |
|
|
|
33 |
Non-consolidated subsidiaries as of Dec. 31, 2021 |
|
|
|
36 |
The list of non-consolidated subsidiaries mainly comprises non-operating shelf companies as well as entities subject to liquidation procedures, which were subsequently measured at fair value through other comprehensive income. Overall, the impact of subsidiaries not consolidated due to immateriality on net sales, profit after tax, assets, and equity was less than 1% relative to the entire Group. The two companies accounted for using the equity method are Syntropy Technologies LLC, United States, and MM Domain Holdco Limited, United Kingdom. In addition, there are two joint operations (Hydrochlor, LLC, United States, and Showa Denko Versum Materials 2 Co., Ltd., Japan) as referred to by IFRS 11. The joint operations are immaterial to the presentation of the financial position and financial performance, both individually and in aggregate. The effects of the existing contractual arrangements also have no potentially significant effect in these contexts.
The list of shareholdings presents all of the companies included in the consolidated financial statements as well as all of the shareholdings of Merck KGaA, Darmstadt, Germany (see Note (48) “List of shareholdings”).